SARS Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines
Conditions:   SARS-CoV-2 Infection;   Varicella;   Measles;   Mumps;   Rubella Interventions:   Biological: Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine;   Biological: Inactivated SARS-CoV-2 vaccine coadministered with MMR;   Biological: Inactivated SARS-CoV-2 vaccine administered alone Sponsors:   Shanghai Municipal Center for Disease Control and Prevention;   China National Biotec Group Company Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2023 Category: Research Source Type: clinical trials